BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 28970150)

  • 1. FLCN: The causative gene for Birt-Hogg-Dubé syndrome.
    Schmidt LS; Linehan WM
    Gene; 2018 Jan; 640():28-42. PubMed ID: 28970150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Birt-Hogg-Dubé syndrome: Clinical and molecular aspects of recently identified kidney cancer syndrome.
    Hasumi H; Baba M; Hasumi Y; Furuya M; Yao M
    Int J Urol; 2016 Mar; 23(3):204-10. PubMed ID: 26608100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Birt-Hogg-Dubé syndrome: from gene discovery to molecularly targeted therapies.
    Schmidt LS
    Fam Cancer; 2013 Sep; 12(3):357-64. PubMed ID: 23108783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Birt-Hogg-Dube syndrome: clinicopathological features of the lung.
    Furuya M; Nakatani Y
    J Clin Pathol; 2013 Mar; 66(3):178-86. PubMed ID: 23223565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular genetics and clinical features of Birt-Hogg-Dubé syndrome.
    Schmidt LS; Linehan WM
    Nat Rev Urol; 2015 Oct; 12(10):558-69. PubMed ID: 26334087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New Developments in the Pathogenesis of Pulmonary Cysts in Birt-Hogg-Dubé Syndrome.
    Kennedy JC; Khabibullin D; Boku Y; Shi W; Henske EP
    Semin Respir Crit Care Med; 2020 Apr; 41(2):247-255. PubMed ID: 32279295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The folliculin-FNIP1 pathway deleted in human Birt-Hogg-Dubé syndrome is required for murine B-cell development.
    Baba M; Keller JR; Sun HW; Resch W; Kuchen S; Suh HC; Hasumi H; Hasumi Y; Kieffer-Kwon KR; Gonzalez CG; Hughes RM; Klein ME; Oh HF; Bible P; Southon E; Tessarollo L; Schmidt LS; Linehan WM; Casellas R
    Blood; 2012 Aug; 120(6):1254-61. PubMed ID: 22709692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folliculin: A Regulator of Transcription Through AMPK and mTOR Signaling Pathways.
    Ramirez Reyes JMJ; Cuesta R; Pause A
    Front Cell Dev Biol; 2021; 9():667311. PubMed ID: 33981707
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical Features, Genetics and Potential Therapeutic Approaches for Birt-Hogg-Dubé Syndrome.
    Schmidt LS; Linehan WM
    Expert Opin Orphan Drugs; 2015; 3(1):15-29. PubMed ID: 26581862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel germline mutations in FLCN gene identified in two Chinese patients with Birt-Hogg-Dubé syndrome.
    Li T; Ning X; He Q; Gong K
    Chin J Cancer; 2017 Jan; 36(1):4. PubMed ID: 28069055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folliculin variants linked to Birt-Hogg-Dubé syndrome are targeted for proteasomal degradation.
    Clausen L; Stein A; Grønbæk-Thygesen M; Nygaard L; Søltoft CL; Nielsen SV; Lisby M; Ravid T; Lindorff-Larsen K; Hartmann-Petersen R
    PLoS Genet; 2020 Nov; 16(11):e1009187. PubMed ID: 33137092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of folliculin (Birt-Hogg-Dubé gene product) with a novel Fnip1-like (FnipL/Fnip2) protein.
    Takagi Y; Kobayashi T; Shiono M; Wang L; Piao X; Sun G; Zhang D; Abe M; Hagiwara Y; Takahashi K; Hino O
    Oncogene; 2008 Sep; 27(40):5339-47. PubMed ID: 18663353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and genetic characteristics of chinese patients with Birt-Hogg-Dubé syndrome.
    Liu Y; Xu Z; Feng R; Zhan Y; Wang J; Li G; Li X; Zhang W; Hu X; Tian X; Xu KF; Zhang X
    Orphanet J Rare Dis; 2017 May; 12(1):104. PubMed ID: 28558743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folliculin encoded by the BHD gene interacts with a binding protein, FNIP1, and AMPK, and is involved in AMPK and mTOR signaling.
    Baba M; Hong SB; Sharma N; Warren MB; Nickerson ML; Iwamatsu A; Esposito D; Gillette WK; Hopkins RF; Hartley JL; Furihata M; Oishi S; Zhen W; Burke TR; Linehan WM; Schmidt LS; Zbar B
    Proc Natl Acad Sci U S A; 2006 Oct; 103(42):15552-7. PubMed ID: 17028174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Birt-Hogg-Dubé: tumour suppressor function and signalling dynamics central to folliculin.
    Tee AR; Pause A
    Fam Cancer; 2013 Sep; 12(3):367-72. PubMed ID: 23096221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of
    Liu L; Yang K; Wang X; Shi Z; Yang Y; Yuan Y; Guo T; Xiao X; Luo H
    Biomed Res Int; 2017; 2017():8751384. PubMed ID: 28785590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folliculin-interacting proteins Fnip1 and Fnip2 play critical roles in kidney tumor suppression in cooperation with Flcn.
    Hasumi H; Baba M; Hasumi Y; Lang M; Huang Y; Oh HF; Matsuo M; Merino MJ; Yao M; Ito Y; Furuya M; Iribe Y; Kodama T; Southon E; Tessarollo L; Nagashima K; Haines DC; Linehan WM; Schmidt LS
    Proc Natl Acad Sci U S A; 2015 Mar; 112(13):E1624-31. PubMed ID: 25775561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Focus on the pulmonary involvement and genetic patterns in Birt-Hogg-Dubè syndrome: Literature review.
    Marziali V; Geropoulos G; Frasca L; Longo F; Patrini D; Panagiotopoulos N; Crucitti P
    Respir Med; 2020 Jul; 168():105995. PubMed ID: 32469710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benign clear cell "sugar" tumor of the lung in a patient with Birt-Hogg-Dubé syndrome: a case report.
    Gunji-Niitsu Y; Kumasaka T; Kitamura S; Hoshika Y; Hayashi T; Tokuda H; Morita R; Kobayashi E; Mitani K; Kikkawa M; Takahashi K; Seyama K
    BMC Med Genet; 2016 Nov; 17(1):85. PubMed ID: 27871249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinctive expression patterns of glycoprotein non-metastatic B and folliculin in renal tumors in patients with Birt-Hogg-Dubé syndrome.
    Furuya M; Hong SB; Tanaka R; Kuroda N; Nagashima Y; Nagahama K; Suyama T; Yao M; Nakatani Y
    Cancer Sci; 2015 Mar; 106(3):315-23. PubMed ID: 25594584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.